Specialized SAP® and Google Cloud Solutions

News & events

Ameri100 Announces $6,000,000 Private Placement

By AMERI100, July 25, 2018

Atlanta, GA, July 25, 2018 — AMERI Holdings, Inc. (Nasdaq: AMRH) (“Ameri100” or the “Company), a specialized SAP® cloud, digital, and enterprise services company, today announced that it has entered into a securities purchase agreement with institutional investors in connection with a private placement of $6,000,000 of shares of its common stock and warrants. The per share purchase price of the common stock is equal to $1.20, and the initial exercise price for the warrants is equal to $1.60 per share, subject to adjustment. In connection with the private placement, the Company will issue 5,000,000 shares of common stock or common stock equivalents and warrants to purchase 4,000,000 shares of common stock, subject to adjustment. The private placement is expected to close on or about July 27, 2018, subject to satisfaction of customary closing conditions.

The Company’s estimated net proceeds from the private placement are expected to be approximately $5.4 million. The Company intends to use the net proceeds for the repayment of certain indebtedness, past acquisition obligations and general corporate purposes.

A.G.P. / Alliance Global Partners acted as the exclusive placement agent for the private placement.

The warrants are exercisable immediately and may be exercised for five years from the date of issuance. The per share purchase price and warrant exercise price will automatically be adjusted lower, if applicable, to 80 percent (with respect to the purchase price of the shares) and 110 percent (with respect to the exercise price of the warrants) of the lowest of the average daily prices on the 6 trading days after the date that (i) a registration statement covering the resale of the securities being issued in the transaction is declared effective by the SEC and (ii) the Company’s shareholders approve the private placement transaction. If all the shares issuable pursuant to the securities purchase agreement are not included in the registration statement, another similar adjustment to the per share purchase price and warrant exercise price will occur on the date that such shares may be sold pursuant to Rule 144 under the Securities Act of 1933. Following any adjustment to the warrant exercise price, the number of shares that may be issued pursuant to a warrant will be proportionately increased. In no event will the purchase price or the warrant exercise price be less than $0.29 per share.

In connection with the private placement, the Company entered into a registration rights agreement with investors whereby the Company agreed to prepare and file a registration statement with the Securities and Exchange Commission (“SEC”) to allow for the registration of the resale of shares of common stock issued in the transaction, as well as the shares of common stock issuable upon exercise of the warrants issued in the transaction.

The Company is obligated to seek shareholder approval of the issuance of the shares issuable in the private placement no later than 60 days after the date of the securities purchase agreement, and it will schedule a meeting of its shareholders for that purpose.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.

The securities purchase agreement and other related agreements can be found in the Company’s Current Report on Form 8-K, which is expected to be filed with the Securities and Exchange Commission on or about July 30, 2018. 

About MedData

MedData, a MEDNAX (NYSE: MD) company, is a leading provider of technology-enabled management services for hospitals and health systems that serve the entire patient financial lifecycle from pre-visit through post-discharge while improving the patient experience and helping them engage better with their providers. For four decades, the company has been providing innovative solutions to the medical community and serving hundreds of millions of patients across numerous medical specialties. MedData currently serves more than 10,000 physicians at a growing network of 3,000+ facilities nationwide from its headquarters in Brecksville, Ohio, and more than 20 regional offices across the U.S. To learn more about MedData’s patient-focused solutions platform, please visit the MedData website.

Forward-Looking Statements

This press release includes forward-looking statements that relate to the business and expected future events or future performance of Ameri100 and involve known and unknown risks, uncertainties and other factors that may cause its actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Words such as, but not limited to, “believe,” “expect,” “anticipate,” “estimate,” “intend,” “plan,” “targets,” “likely,” “will,” “would,” “could,” and similar expressions or phrases identify forward-looking statements. Forward-looking statements include, but are not limited to, statements about Ameri100’s financial and growth projections as well as statements concerning our plans, predictions, estimates, strategies, intentions, beliefs and other information concerning our business and the markets in which we operate. The future performance of Ameri100 may be adversely affected by the following risks and uncertainties: our inability to obtain financing to replace our existing credit facility with Sterling National Bank prior to its termination, the level of market demand for our services, the highly-competitive market for the types of services that we offer, market conditions that could cause our customers to reduce their spending for our services, our ability to create, acquire and build new businesses and to grow our existing businesses, our ability to attract and retain qualified personnel, currency fluctuations and market conditions around the world, and other risks not specifically mentioned herein but those that are common to industry. For a more detailed discussion of these factors and risks, investors should review Ameri100’s reports on Form 10-K and other reports filed with the Securities and Exchange Commission (the “SEC”), which can be accessed through the SEC’s website. Forward-looking statements in this press release are based on management’s beliefs and opinions at the time the statements are made. All forward-looking statements are qualified in their entirety by this cautionary statement, and Ameri100 undertakes no duty to update this information to reflect future events, information or circumstances.

Corporate Contact:

Viraj Patel, Chief Financial Officer


Investor Relations Contact:

Sanjay M. Hurry

LHA Investor Relations

(212) 838-3777


SOURCE AMERI Holdings, Inc.

Interested In Learning More?

Contact us.